Drugmaker AbbVie is acquiring a biotech firm for nearly $11 billion seeking to bolster its drug portfolio.
Follow US
Find US on Social Medias
Popular News
Global Coronavirus Cases
Confirmed
0
Death
0
Search
Confirmed
0
Death
0